28
Views
15
CrossRef citations to date
0
Altmetric
Review

Cell transplantation for treatment of left-ventricular dysfunction due to ischemic heart failure: from bench to bedside

, , , &
Pages 125-131 | Published online: 10 Jan 2014

References

  • Erickson H. Heart failure: a growing public health problem. J. Intern. Med.237, 135–141 (1995).
  • American Heart association .2002 Statistical update. Dallas, TX: American heart association.
  • Pfeffer JM, Pfeffer MA, Fltcher PF, Braunwald E. Progressive ventricular remodeling in rat with myocardial infarction. Am. J. Physiol.260, 1406–1414 (1991).
  • Beltrami AP, Urbanek K, Kajstura J et al. Evidence that human cardiac myocytes divide after myocardial infarction. N. Engl. J. Med.334, 1750–1757 (2001).
  • Anversa P, Nadal-ginard B. Myocyte renewal and ventricular remodeling. Nature415, 240–243 (2002).
  • Quaini F, Urbanek K, Beltrami AP et al. Chimerism of the transplanted heart. N. Engl. J. Med.346, 5–15 (2002).
  • Chachques JC, Shafy A, Duarte F et al. From dynamic to cellular cardiomyoplasty. J. Card. Surg.17, 194–200 (2002).
  • Chiu RCJ. Therapeutic cardiac angiogenesis and myogenesis: the promises and challenges on a new frontier. J. Thorac. Cardiovasc. Surg.122, 851–852 (2001).
  • Rajnoch C, Chachques JC, Berrebi A, Bruneval P, Benoit MO, Carpentier A. Cellular therapy reverses myocardial dysfunction. J. Thorac. Cardiovasc. Surg.121, 871–878 (2001).
  • Glaser R, Lu MM, Narula N, Epstein JA. Smooth muscle cells, but not myocytes, of host origin in transplanted human hearts. Circulation106, 17–19 (2002).
  • Mack CA, Patel SR, Schwartz, EA et al. Biologic bypass with the use of adenovirus mediated gene transfer of the deoxyribonucleic acid for VEGF12 improves myocardial perfusion and function in the ischemic porcine heart. J. Thorac. Cardiovasc. Surg.115, 168–177 (1998).
  • Perin EC, Geng YJ, Willerson JT. Adult stem cell therapy in perspective. Circulation107, 935–938 (2003).
  • Zhang YM, Hartzell C, Narlow M, Dudley SC Jr. Stem cell derived cardiomyocytes demonstrates arrhythmic potential. Circulation.106, 1294–1299 (2002).
  • Jiang Y, Jahagirdar BN, Reinhardt RL et al. Pleuripotency of mesenchymal stem cells derived from adult marrow. Nature418, 41–49 (2002).
  • Pagani FD, DerSimonian H, Zawadzka A et al. Autologous skeletal myoblasts transplanted to ischemia-damaged myocardium in humans. Histological analysis of cell survival and differentiation. J. Am. Coll. Cardiol.41, 879–888 (2003).
  • Dib N, McCarthy P, Campbell A et al. Two-year follow-up of the safety and feasibility of autologous myoblast transplantation in patients with ischemic cardiomyopathy: Results from the United States experience. Circulation108, IV-623 (2003).
  • Monnet E, Chachques JC. Animal models of heart failure: what is new? Ann Thor Surg. 79, 1445–1453 (2005).
  • Swindle MM & Adams RJ. Experimental Surgery and Physiology: Induced Animal Models of human Disease. Williams & Wilkins, MD, USA (1988).
  • McGoon DC. The ongoing quest for ideal myocardial protection. A catalog of the recent English literature. J. Thorac. Cardiovasc. Surg.89, 639–653 (1985).
  • Wallukat WG, Heschheler J. Pluripotent mouse embryonic stem cells are able to differentiate into cardiomyocytes expressing chronotropic responses to adrenergic abd cholinergic agents and Ca2+ channel blockers. Differentiation48, 173–182 (1991).
  • Kawamoto A, Tkebuchava T, Yamaguchi J et al. Intramyocardial transplantation of autologous endothelial progenitor cells for therapeutic neovascularization of myocardial ischemia. Circulation107, 461–468 (2003).
  • Klug MG, Soonpaa MH, Koh GY et al. Genetically selected cardiomyocytes from differentiating embryonic stem cells form stable intracardiac grafts. J. Clin. Invest.98, 216–224 (1996).
  • Yokomuro H, Li RK, Mickle DA et al. Transplantation of cryopreserved cardiomyocytes. J. Thorac. Cardiovasc. Surg.121, 98–107 (2001).
  • Ott HC, Davis BH, Taylor DA..Cell therapy for heart failure – muscle, bone marrow, blood, and cardiac-derived stem cells. Semin. Thorac. Cardiovasc. Surg.17, 348–360 (2005).
  • Orlic D, Kajstura J, Chimenti S et al. Bone marrow cells regenerate infarcted myocardium. Nature410, 701–705 (2001).
  • Toma C, Pittenger MF, Cahill KS et al. Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart. Circulation105, 93–98 (2002).
  • Perin EC, Silva GV, Sarmento-Leite R et al. Assessing myocardial viability and infarct transmurality with left ventricular electromechanical mapping in patients with stable coronary artery disease: validation by delayed-enhancement magnetic resonance imaging. Circulation.106, 957–961 (2002).
  • Perin EC, Silva GV, Leite RS. Left ventricular electromechanical mapping as a diagnostic method. In: Myocardial Revascularization: Novel Percutaneous Approaches. Abela GS (Ed.). Wiley-Liss, NY, USA183–195 (2001).
  • Gepstein L. Hayam G. Shpun S. Ben-Haim SA. Hemodynamic evaluation of the heart with a nonfluoroscopic electromechanical mapping technique. Circulation.96, 3672–3680 (1997).
  • Chachques JC. Acar C. Herreros J et al Cellular cardiomyoplasty: clinical application. Ann. Thorac. Surg..77, 1121–1130 (2004).
  • Miller PJ. An elastic stain. Med. Lab. Technol.28, 148–149 (1971).
  • Herreros J, Prosper F, Perez A et al. Autologous intramyocardial injection of cultured skeletal muscle-derived stem cells in patients with non-acute myocardial infarction. Europ. Heart J.24, 2012–2020 (2003).
  • Steendijk P, Smits PC, Valgimigli M, van der Giessen WJ, Onderwater EE, Serruys PW. Intramyocardial injection of skeletal myoblasts: long-term follow-up with pressure-volume loops. Nat. Clin. Pract. Cardiovasc. Med.3(Suppl. 1), S94–S100 (2006).
  • Dohmann HF, Perin EC, Tahiya CM et al. Transendocardial autologous bone marrow mononuclear cell injection in ischemic heart failure: postmortem anatomicopathologic and immunohistochemical findings. Circulation.112, 521–526 (2005).
  • Strauer BE, Brehm M, Zeus T et al. Repair of infarcted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans. Circulation106, 1913–1918 (2002).
  • Tse HF, Kwong YL, Chan JK et al. Angiogenesis in ischemic myocardium by intramyocardial autologous bone marrow mononuclear cell implantation. Lancet361, 47–49 (2003).
  • Wollert KC, Meyer GP, Lotz J et al. Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial. Lancet.364(9429), 141–148 (year).
  • Kang HJ, Kim HS, Zhang SY et al. Effects of intracoronary infusion of peripheral blood stem-cells mobilised with granulocyte-colony stimulating factor on left ventricular systolic function and restenosis after coronary stenting in myocardial infarction: the MAGIC cell randomised clinical trial. Lancet363, 746–747 (2004).
  • Stamm C, Westphal B, Kleine HD et al. Autologous bone-marrow stem-cell transplantation for myocardial regeneration. Lancet361, 45–46 (2003).
  • Assmus B, Schächinger V, Teupe C et al. Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction (TOPCARE-AMI). Circulation.106, 3009–3017 (2002).
  • Perin E, Dohmann HF, Borojevic R et al. Transendocardial, Autologous Bone Marrow Cell Transplantation for Severe, Chronic Ischemic Heart Failure. Circulation.107, 2294–2302 (2003).
  • Epstein SE, Kornowski R, Fuchs S et al. Angiogenesis therapy. amidst the hype, the neglected potential for serious side effects. Circulation.104, 115 (2001).
  • Menasche P, Desnos M. Cardiac reparation: fixing the heart with cells, new vessels and genes. Eur. Heart J.4, D73–D81 (2002).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.